NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 74.01% | -967.05% | -- | 47.08% |
| Total Depreciation and Amortization | 0.00% | 39.35% | 0.00% | -- | 8.67% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -93.38% | 3,178.52% | -- | -92.43% |
| Change in Net Operating Assets | 0.00% | -128.11% | 46.95% | -- | -106.28% |
| Cash from Operations | 0.00% | -12.79% | -893.69% | -- | -230.00% |
| Capital Expenditure | 0.00% | -- | -- | -- | -3,700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | 99.91% |
| Cash from Investing | 0.00% | -- | -- | -- | 99.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 85.50% | -99.68% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -233.64% | -- | -- |
| Cash from Financing | 0.00% | 112.27% | -104.98% | -- | -- |
| Foreign Exchange rate Adjustments | 0.00% | -114.44% | 156.16% | -- | -101.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 42.65% | -127.82% | -- | 84.77% |